Boule Diagnostics
4.08 SEK
+0.99 %
Less than 1K followers
BOUL
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Boule Diagnostics
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 130.4 | 143.3 | 558.5 | 112.9 | 129.3 | 127.2 | 120.2 | 489.6 |
| EBITDA | -278.9 | 4.7 | -257.4 | -6.4 | 1.3 | 21.7 | 15.4 | 32.0 |
| EBIT | -278.9 | 4.7 | -257.4 | -6.4 | 1.3 | 16.7 | 10.7 | 22.3 |
| EBIT-% | -213.9 % | 3.3 % | -46.1 % | -5.7 % | 1.0 % | 13.1 % | 8.9 % | 4.6 % |
| Profit before taxes | -281.6 | 1.0 | -268.5 | -9.6 | -4.0 | 13.5 | 6.2 | 6.1 |
| Net income | -229.2 | -2.3 | -223.3 | -10.3 | -5.7 | 10.9 | 1.6 | -3.5 |